_version_ 1783234466791030784
author Schlenk, R F
Frech, P
Weber, D
Brossart, P
Horst, H-A
Kraemer, D
Held, G
Ringhoffer, M
Burchardt, A
Kobbe, G
Götze, K
Nachbaur, D
Fischer, T
Lübbert, M
Salih, H R
Salwender, H
Wulf, G
Koller, E
Wattad, M
Fiedler, W
Kremers, S
Kirchen, H
Hertenstein, B
Paschka, P
Gaidzik, V I
Teleanu, V
Heuser, M
Thol, F
Döhner, K
Krauter, J
Ganser, A
Döhner, H
author_facet Schlenk, R F
Frech, P
Weber, D
Brossart, P
Horst, H-A
Kraemer, D
Held, G
Ringhoffer, M
Burchardt, A
Kobbe, G
Götze, K
Nachbaur, D
Fischer, T
Lübbert, M
Salih, H R
Salwender, H
Wulf, G
Koller, E
Wattad, M
Fiedler, W
Kremers, S
Kirchen, H
Hertenstein, B
Paschka, P
Gaidzik, V I
Teleanu, V
Heuser, M
Thol, F
Döhner, K
Krauter, J
Ganser, A
Döhner, H
author_sort Schlenk, R F
collection PubMed
description
format Online
Article
Text
id pubmed-5420792
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-54207922017-05-19 Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia Schlenk, R F Frech, P Weber, D Brossart, P Horst, H-A Kraemer, D Held, G Ringhoffer, M Burchardt, A Kobbe, G Götze, K Nachbaur, D Fischer, T Lübbert, M Salih, H R Salwender, H Wulf, G Koller, E Wattad, M Fiedler, W Kremers, S Kirchen, H Hertenstein, B Paschka, P Gaidzik, V I Teleanu, V Heuser, M Thol, F Döhner, K Krauter, J Ganser, A Döhner, H Leukemia Letter to the Editor Nature Publishing Group 2017-05 2017-02-03 /pmc/articles/PMC5420792/ /pubmed/28096533 http://dx.doi.org/10.1038/leu.2017.22 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Schlenk, R F
Frech, P
Weber, D
Brossart, P
Horst, H-A
Kraemer, D
Held, G
Ringhoffer, M
Burchardt, A
Kobbe, G
Götze, K
Nachbaur, D
Fischer, T
Lübbert, M
Salih, H R
Salwender, H
Wulf, G
Koller, E
Wattad, M
Fiedler, W
Kremers, S
Kirchen, H
Hertenstein, B
Paschka, P
Gaidzik, V I
Teleanu, V
Heuser, M
Thol, F
Döhner, K
Krauter, J
Ganser, A
Döhner, H
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
title Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
title_full Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
title_fullStr Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
title_full_unstemmed Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
title_short Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
title_sort impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420792/
https://www.ncbi.nlm.nih.gov/pubmed/28096533
http://dx.doi.org/10.1038/leu.2017.22
work_keys_str_mv AT schlenkrf impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT frechp impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT weberd impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT brossartp impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT horstha impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT kraemerd impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT heldg impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT ringhofferm impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT burchardta impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT kobbeg impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT gotzek impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT nachbaurd impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT fischert impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT lubbertm impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT salihhr impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT salwenderh impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT wulfg impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT kollere impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT wattadm impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT fiedlerw impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT kremerss impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT kirchenh impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT hertensteinb impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT paschkap impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT gaidzikvi impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT teleanuv impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT heuserm impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT tholf impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT dohnerk impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT krauterj impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT gansera impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT dohnerh impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia
AT impactofpretreatmentcharacteristicsandsalvagestrategyonoutcomeinpatientswithrelapsedacutemyeloidleukemia